WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of WEXRUCMBJFQVBZ-UHFFFAOYSA-N.svg
tripsit

pentobarbital

Vérifier sur tripsit

psychonaut

Pentobarbital

Vérifier sur psychonaut

isomerdesign

Pentobarbital

Vérifier sur isomerdesign

pubchem

Pentobarbital

Vérifier sur pubchem

druglab

Pentobarbital

Vérifier sur druglab

drugmap

Pentobarbital

Vérifier sur drugmap

wiki

Pentobarbital

Vérifier sur wiki

Data

InChI: InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)

Synonymes: Pentobarbituric acid,Mebubarbital,Sodium pentobarbital,HMS3713B10,KBio2_002266,Pentobarbital cii,NSC760434, Pentobarbiturate,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-,DTXCID003435,5-Ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione, Pentabarbital,I4744080IR,EINECS 200-983-8,novopentobarb,2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-,KBio2_004834,(+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid,PENTOBARBITAL [MI],Spectrum5_001705,Spectrum_001783,GTPL5480, Ethaminal,SCHEMBL24966, Nembutal (VAN),DSSTox_GSID_23435,NSC28708,Spectrum3_001783,Tox21_111555,CCG-39476,CHEMBL448, 5-Ethyl-5-(sec-pentyl)barbituric acid,Pentobarbitalum [INN-Latin], Pentobarbitone, Pentobarbital calcium,PENTOBARBITAL [VANDF],component of Emesert (Salt/Mix),5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione, Pentobarbital, Monosodium Salt,Q409632,Pentobarbital [USP:INN:BAN],PENTOBARBITAL [MART.],Barbituric acid, 5-ethyl-5-(1-methylbutyl)-,5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione, Rivadorm,Pentobarbitone (VAN), Pentobarbital [USP:INN], 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Continal (Salt/Mix),Pentobarbitale,PENTOBARBITAL [USP MONOGRAPH], Nebralin,Pentobarbital calcium, Mebubarbital,Neodorm,HMS2094E21,5-Ethyl-5-(1-methylbutyl)malonylurea,SR-05000001789,PENTOBARBITAL [HSDB],PENTOBARBITAL [EP MONOGRAPH], Neodorm (VAN),component of Synirin (Salt/Mix),Ethaminal, Etaminal,PENTOBARBITAL [WHO-DD],Pentobarbitale [DCIT],5-24-09-00168 (Beilstein Handbook Reference),SBI-0052713.P002,Pentobarbital 0.1 mg/ml in Methanol, Pentobarbital suppository dosage form,Nebralin,Pentobarbital (VAN),CCG-220564,DSSTox_RID_77026,Neodorm (VAN),Pentobarbiturate,(+/-)-5-ETHYL-5-(1-METHYLBUTYL)BARBITURIC ACID,DivK1c_000992, Mebumal, Neodorm,KBio2_007402,Ethyl-propylmethylcarbinylbarbituric acid,Pentobarbital, European Pharmacopoeia (EP) Reference Standard,057P561,Nembutal,SCHEMBL11114711,KBioGR_001008,Nembutal (TN), Pentobarbitalum [INN-Latin],Nembutal (VAN),SR-01000317092-2, Neodorm (new),UNII-I4744080IR,5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione,WLN: T6VMVMV FHJ FY3&1 F2, Nembutal,Phetobarbitone,Oprea1_775730,PENTOBARBITAL [ORANGE BOOK],PENTOBARBITAL [GREEN BOOK],KBio1_000992,BSPBio_003305,Oprea1_143902,CCRIS 7089,DB-056119, 5-Ethyl-5-(1-methylbutyl)malonylurea,5-Ethyl-5-(1-methylbutyl)barbituric acid,Pentobarbital,HSDB 3151,CAS-76-74-4,NCGC00344563-01,nembutal,Pentobarbital [INN],THIOPENTAL SODIUM IMPURITY B [EP IMPURITY],NCGC00096074-01,Sedalixir (Salt/Mix), Pentobarbital (VAN),57-33-0,Pentabarbital,Pentobarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,SR-01000317092,(.+/-.))-Pentobarbital, 5-Ethyl-5-(1-methylbutyl)barbituric acid, Pentobarbituric acid,SPBio_002201,Sagatal,5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Pentabarbitone,SR-05000001789-1,Pentobarbital (USP/INN),CHEBI:7983,BRD-A44448661-001-01-4,EC 200-983-8,DTXSID7023435,PENTOBARBITAL CII [USP-RS],KBioSS_002267,DB00312,BDBM50055935,5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione,Aethaminalum, (+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid, Pentobarbitale,NSC-28708, Pentobarbital (USP/INN),Neodorm (new),5-Ethyl-5-(sec-pentyl)barbituric acid,Mebumal,C07422, 5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione, Pentobarbitale [DCIT],NCGC00096074-02,pentobarbital, Pentobarbitone (VAN),Barbituric acid, 5-ethyl-5-(2-pentyl)-,5-Ethyl-5-(1-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione,2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5-ETHYL-5-(1-METHYLBUTYL)-, (+/-)-,AKOS000277861,DSSTox_CID_3435, Ethyl-propylmethylcarbinylbarbituric acid,Pentobarbital 1.0 mg/ml in Methanol,STL367899,NINDS_000992, Pentabarbitone,5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione,HMS503G05,NSC 28708,IDI1_000992,SPECTRUM1900006,Dorsital,Spectrum4_000574, Nembutal (TN),Pentobarbitone,Pentobarbitalum, Pentobarbitalum,Spectrum2_001991,(plusmn)-pentobarbital,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, Dorsital,Pentobarbital, United States Pharmacopeia (USP) Reference Standard,NSC-760434,BRN 0087067,76-74-4,D00499,KBio3_002807,Rivadorm, 5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione,(RS)-pentobarbital,Pharmakon1600-01900006


Estimated data

Solubility: -2.079 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 37.5% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.